After-Hours Stock Movers 09/02: (APOP) (MDB) (PD) Higher; (FBRX) (YEXT) (JOAN) Lower (more...)

After-Hours Stock Movers

Forte Biosciences, Inc. (NASDAQ: FBRX) 82.4% LOWER; announced that topline data from its Phase 2 clinical trial of FB-401 for the treatment of atopic dermatitis failed to meet statistical significance for the primary endpoint of EASI-50 (the proportion of patients with at least a 50% improvement in atopic dermatitis disease severity as measure by EASI).

Cellect Biotechnology Ltd. (NASDAQ: APOP) 12.1% HIGHER; announced the first ApoGraftTM transplantation in a Leukemia patient in the Company’s clinical trial at Washington University in the U.S. ApoGraftTM is a product based on the Company’s cell selection technology designed to optimize immune therapy, in this application - prevent graft-versus-host disease (GVHD) following bone marrow transplantation.

MongoDB (NASDAQ: MDB) 12.3% HIGHER; reported Q2 EPS of ($0.24), $0.15 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $198.7 million versus the consensus estimate of $184.2 million. MongoDB sees Q3 2022 EPS of ($0.42)-($0.39), versus the consensus of ($0.37). MongoDB sees Q3 2022 revenue of $202-204 million, versus the consensus of $198.3 million. MongoDB sees FY2022 EPS of ($1.20)-($1.13), versus the consensus of ($1.29). MongoDB sees FY2022 revenue of $805-811 million, versus the consensus of $786.06 million.

Yext, Inc. (NYSE: YEXT) 11.6% LOWER; reported Q2 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $98.1 million versus the consensus estimate of $95.03 million. Yext, Inc. sees Q3 2022 EPS of ($0.06)-($0.08), versus the consensus of ($0.05). Yext, Inc. sees Q3 2022 revenue of $97.5-98.5 million, versus the consensus of $97.23 million. Yext, Inc. sees FY2022 EPS of ($0.20)-($0.24), versus the consensus of ($0.18). Yext, Inc. sees FY2022 revenue of $386-388 million, versus the consensus of $385.2 million.

PagerDuty, Inc. (NYSE: PD) 11.4% HIGHER; reported Q2 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $67.5 million versus the consensus estimate of $65.56 million. PagerDuty, Inc. sees FY2022 EPS of ($0.39)-($0.35), versus the consensus of ($0.39). PagerDuty, Inc. sees FY2022 revenue of $273-276 million, versus the consensus of $270 million.

JOANN Inc (NASDAQ: JOAN) 9.5% LOWER; reported Q2 EPS of $0.12, $0.25 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $496.9 million versus the consensus estimate of $533.2 million.

Ooma (NYSE: OOMA) 6.9% HIGHER; reported Q2 EPS of $0.13, $0.05 better than the analyst estimate of $0.08. Revenue for the quarter came in at $47.1 million versus the consensus estimate of $46.25 million.

Guidewire Software (NYSE: GWRE) 5.5% HIGHER; reported Q4 EPS of $0.37, $0.12 better than the analyst estimate of $0.25. Revenue for the quarter came in at $229.4 million versus the consensus estimate of $222.35 million. Guidewire Software sees Q1 2022 revenue of $162-166 million, versus the consensus of $174.6 million. Guidewire Software sees FY2022 revenue of $780-790 million, versus the consensus of $769.23 million.

Tilly's, Inc. (NYSE: TLYS) 2.2% LOWER; reported Q2 EPS of $0.66, $0.23 better than the analyst estimate of $0.43. Revenue for the quarter came in at $202 million versus the consensus estimate of $187.97 million. Tilly's, Inc. sees Q3 2021 EPS of $0.30-$0.34, versus the consensus of $0.23. Tilly's, Inc. sees Q3 2021 revenue of $187-193 million, versus the consensus of $170 million.

Beyond Meat (NASDAQ: BYND) 1.7% LOWER; Sanjay Shah notified Beyond Meat (NASDAQ: BYND) that he is stepping down as the Company’s Chief Operating Officer effective immediately. Mr. Shah’s responsibilities will be performed by Jonathan P. Nelson, the Company’s current Vice President, NA Manufacturing Operations, while the Company conducts a search for Mr. Shah’s replacement.

Science Applications Int'l (NYSE: SAIC) 1.3% HIGHER; reported Q2 EPS of $1.97, $0.50 better than the analyst estimate of $1.47. Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.79 billion. Science Applications Int'l sees FY2022 EPS of $6.50-$6.70, versus the consensus of $6.51. Science Applications Int'l sees FY2022 revenue of $7.3-7.4 billion, versus the consensus of $7.33 billion.

Hewlett Packard Enterprise (NYSE: HPE) 0.7% LOWER; reported Q3 EPS of $0.47, $0.05 better than the analyst estimate of $0.42. Revenue for the quarter came in at $6.9 billion versus the consensus estimate of $6.91 billion. Hewlett Packard Enterprise sees Q4 2021 EPS of $0.44-$0.52, versus the consensus of $0.49. Hewlett Packard Enterprise sees FY2021 EPS of $1.88-$1.96, versus the consensus of $1.89.

DocuSign Inc. (NASDAQ: DOCU) 0.7% LOWER; reported Q2 EPS of $0.47, $0.07 better than the analyst estimate of $0.40. Revenue for the quarter came in at $511.8 million versus the consensus estimate of $487.5 million. DocuSign Inc. sees Q3 2022 revenue of $526-532 million, versus the consensus of $520.62 million. DocuSign Inc. sees FY2022 revenue of $2.078-2.088 billion, versus the consensus of $2.05 billion.

Broadcom (NASDAQ: AVGO) 0.5% LOWER; reported Q3 EPS of $6.96, $0.11 better than the analyst estimate of $6.85. Revenue for the quarter came in at $6.78 billion versus the consensus estimate of $6.74 billion. Broadcom sees Q4 2021 revenue of ~$7.35 billion, versus the consensus of $7.23 billion.

You May Also Be Interested In

• After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
• Chipmakers in focus: Intel and AMD gear up for Q1 earnings report
• After-hours movers: Tesla, Gildan Activewear, Macatawa Bank, and more